Nanoviricides (NNVC) Enterprise Value (2010 - 2026)

Nanoviricides has disclosed Enterprise Value across 17 years of filings, most recently posting $16.5 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 1.66% year-over-year to $16.5 million; the TTM figure through Mar 2026 stood at $16.5 million (up 1.66% YoY), while the FY2025 annual figure was $21.7 million, up 21.79% from the prior year.
• Enterprise Value came in at $16.5 million for Q1 2026 at Nanoviricides, down from $19.2 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $24.0 million in Q3 2025 to a low of $1.5 million in Q4 2022.
• Average Enterprise Value over 5 years is $12.4 million, with a median of $10.4 million recorded in 2024.
• Year-over-year, Enterprise Value sank 94.27% in 2022 and soared 361.71% in 2023.
• Over 5 years, Enterprise Value stood at $1.5 million in 2022, then soared by 361.71% to $6.8 million in 2023, then jumped by 171.35% to $18.4 million in 2024, then grew by 4.55% to $19.2 million in 2025, then retreated by 13.91% to $16.5 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $16.5 million in Q1 2026, $19.2 million in Q4 2025, and $24.0 million in Q3 2025.